Ardent Health Inc(ARDT) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Oct 28 at 5:05 PM ET (Korea 10/29 06:05)
Full metrics table
| Index | RUT | P/E | 21.72 | EPS (ttm) | 0.55 | Insider Own | 84.41% | Shs Outstand | 141.9M | Perf Week | -1.08% |
| Market Cap | 1.68B | Forward P/E | 10.24 | EPS next Y | 21.97% | Insider Trans | 0.02% | Shs Float | 22.0M | Perf Month | 12.76% |
| Enterprise Value | 3.62B | PEG | 1.04 | EPS next Q | 0.24 | Inst Own | 15.67% | Short Float | 17.07% | Perf Quarter | 11.18% |
| Income | 0.08B | P/S | 0.26 | EPS this Y | -0.53% | Inst Trans | 1.1% | Short Ratio | 8.56 | Perf Half Y | 23.88% |
| Sales | 6.41B | P/B | 1.25 | EPS next 5Y | 9.86% | ROA | 1.52% | Short Interest | 3.75M | Perf YTD | 35.11% |
| Book/sh | 9.52 | P/C | 2.32 | EPS past 3/5Y | -10.04% - | ROE | 6.01% | 52W High | -22.93% ($15.48) | Perf Year | -20.94% |
| Cash/sh | 5.14 | P/FCF | 5.57 | Sales past 3/5Y | 7.23% 8.73% | ROIC | 2.18% | 52W Low | 54.73% ($7.71) | Perf 3Y | - |
| Dividend Est. | - | EV/EBITDA | 8.56 | EPS Y/Y TTM | -69.26% | Gross Margin | 14.84% | Volatility(W/M) | 3% 3.7% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | 0.56 | Sales Y/Y TTM | 3.34% | Oper. Margin | 4.03% | ATR (14) | 0.41 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 1.99 | EPS Q/Q | -77.09% | Profit Margin | 1.22% | RSI (14) | 58.08 | Recom | 2 |
| Dividend Gr. 3/5Y | - | Current Ratio | 2.1 | Sales Q/Q | -1.4% | SMA20 | 3.37% ($11.54) | Beta | 0.7 | Target Price | $12.67 |
| Payout | - | Debt/Eq | 1.68 | Earnings | 2026/11/4 | SMA50 | 7.48% ($11.1) | Rel Volume | 0.86 | Prev Close | $11.83 |
| Employees | 25200 | LT Debt/Eq | 1.66 | EPS/Sales Surpr. | -33.96% 2.05% | SMA200 | 19.91% ($9.95) | Avg Volume(3M) | 0.44M | Price | $11.93 |
| IPO | 2024/7/18 | Option/Short | Yes/Yes | Trades | 2704 | Volume | 376,883 | Change | 0.85% |
Adent Health (ARDT) is a healthcare services company that operates general hospitals and outpatient care facilities across multiple U.S. states. It provides a wide range of medical services, from emergency, surgical, and specialty care to telemedicine and urgent care, and delivers both patient care and medical operations based on its network of regional anchor hospitals. The company is headquartered in the United States and maintains an extensive portfolio of hospital and outpatient facilities.
Over the past 1 year, roughly in the middle
23% below its 1-year high.
Traded about as much as usual. That is 86% of its average volume.
Next earnings report: November 4
7 days to go.
ARDT earns at a steady pace
Of every $100 in sales, $4.03 is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by -0.5% this year.
Tap to view numbers
The price is about the industry average
Counting its debt, for $100 of yearly operating cash you would pay $856. Peers typically go for $1,316. Compared with its own 2-year average, it is 113% pricier now.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 4 quarters.
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Buy.
Tap to view numbers
Holding long would have lost money
Tap to view numbers
No dividend
It reinvests profits in the business instead of paying dividends.
Ownership is about average
Institutions hold 15.7%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #24 of 48 in the industry
Based on market cap of $2B.
FAQ
What kind of company is ARDT?
ARDT belongs to the Healthcare sector and operates in the Medical Care Facilities industry.
What is the market cap of ARDT?
The market cap of ARDT is approximately $1.7B, ranking 2,207 within its sector.
What is the P/E ratio of ARDT?
ARDT has a P/E ratio of approximately 21.7x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for ARDT?
ARDT has recorded a 52-week high of $15.48 and a low of $7.71.
